You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華潤醫藥(03320.HK)子公司與海口國家高新區簽署合作協議
華潤醫藥(03320.HK)公佈,旗下子公司華潤雙鶴一類抗癌藥落地暨海口國家高新區與華潤雙鶴簽約儀式,於昨日(11日)在海口市政府辦公樓舉行。雙方現場簽署了《海口國家高新區管理委員會與華潤雙鶴藥業股份有限公司合作協議》。 集團指,此次簽約是華潤雙鶴獲得美國Novita公司一類抗癌藥獨家授權協議後,在海南推進該化合物實現產業化落地的重要保障,此舉將爲海南建立開放型經濟新體系和新格局提供助力,同時亦將助力公司實現創新轉型,成長爲海南自貿港的科技領軍企業,進一步夯實集團的市場競爭力。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account